ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

December Business & Regulatory Report included in this issue.

December 12, 2003

FCRF Recompetition Notice Of Intent

September 19, 1980

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012